EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of DPP4 Gene Variants with Classic and DPP4 Inhibitor-Associated Bullous Pemphigoid

Charoula Achilla iD, Christina Foutsitzidou, Parthena Meltzanidou, Aikaterini Patsatsi iD, Elizabeth Lazaridou iD, Glykeria Tzatzagou, Alexandros Lambropoulos iD, Anthoula Chatzikyriakidou iD

International Journal of Molecular Sciences · 03.12.2025 · 26 (23) · 11698

DOI: 10.3390/ijms262311698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.12.2025. Verfasst von Charoula Achilla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Biology-Genetics, Medical School, Aristotle University, 54124 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Dipeptidyl-Peptidase IV Inhibitors, Dipeptidyl Peptidase 4, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bullous pemphigoid (BP), the most prevalent autoimmune blistering skin disorder, has been associated with dipeptidyl peptidase-4 inhibitor (DPP4i) treatment in type 2 diabetic patients. This study aimed to investigate the association of DPP4 gene variants, rs3788979 and rs12617656, with classic BP (cBP)- and DPP4i-associated BP predisposition. Fifty-six (56) unrelated patients with cBP, 32 DPP4i-associated BP patients, 60 healthy controls, and 49 diabetic patients receiving DPP4i were included. Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism assay (PCR-RFLP). Statistical analyses were conducted using SPSS software. For rs3788979, the CT+TT genotypes were significantly associated with increased risk of DPP4i-associated BP compared with cBP [(Odds Ratio (OR) = 2.80, 95% Confidence Interval (CI) = 1.07–7.35; p-value = 0.034] and healthy controls (OR = 0.30, 95% CI = 0.13–0.86; p-value = 0.020). The T allele was also enriched in DPP4i-associated BP (OR = 2.57, 95% CI = 1.09–6.07; p-value = 0.027). Additionally, the TC genotype of rs12617656 (OR = 2.29, 95% CI = 1.04–5.03, p-value = 0.039) showed significant association with cBP susceptibility. These findings highlight DPP4 variants as potential BP risk factors, supporting personalized risk assessment prior to initiating gliptin therapy. Large-scale studies are warranted to validate these associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousDipeptidyl-Peptidase IV InhibitorsDipeptidyl Peptidase 4Polymorphism, Single NucleotideGenetic Predisposition to DiseaseHumansMaleFemaleMiddle AgedAgedDiabetes Mellitus, Type 2Case-Control StudiesGenotypeAlleles

Stichwörter der Autor:innen

DPP4 geneDPP4i-associated bullous pemphigoidbullous pemphigoiddipeptidyl peptidase-4 inhibitor (DPP4i)gliptinsvariant

Substanzen

Dipeptidyl-Peptidase IV InhibitorsDipeptidyl Peptidase 4DPP4 protein, human

Autor:innen und Institutionen

  • Laboratory of Medical Biology-Genetics, Medical School, Aristotle University, 54124 Thessaloniki, Greece.
  • Genetics Unit, 1st Department of Obstetrics and Gynecology, Papageorgiou General Hospital, Medical School, Aristotle University, 56403 Thessaloniki, Greece.
  • Pemphig Center, Papageorgiou General Hospital, Medical School, Aristotle University, 56403 Thessaloniki, Greece.
  • 2nd Department of Dermatology, Papageorgiou General Hospital, Medical School, Aristotle University, 56403 Thessaloniki, Greece.
  • 1st Department of Internal Medicine, Papageorgiou General Hospital, Medical School, Aristotle University, 56403 Thessaloniki, Greece.

ORCID-Profile: Charoula Achilla, Aikaterini Patsatsi, Elizabeth Lazaridou, Alexandros Lambropoulos, Anthoula Chatzikyriakidou

Zitieren

APA

Achilla, C., Foutsitzidou, C., Meltzanidou, P., Patsatsi, A., Lazaridou, E., Tzatzagou, G., Lambropoulos, A., & Chatzikyriakidou, A. (2025). Association of DPP4 Gene Variants with Classic and DPP4 Inhibitor-Associated Bullous Pemphigoid. International Journal of Molecular Sciences, 26(23), 11698. https://doi.org/10.3390/ijms262311698

Vancouver

Achilla C, Foutsitzidou C, Meltzanidou P, Patsatsi A, Lazaridou E, Tzatzagou G, et al. Association of DPP4 Gene Variants with Classic and DPP4 Inhibitor-Associated Bullous Pemphigoid. International Journal of Molecular Sciences. 2025;26(23):11698. doi:10.3390/ijms262311698

BibTeX
@article{Achilla2025,
  author = {Achilla, Charoula and Foutsitzidou, Christina and Meltzanidou, Parthena and Patsatsi, Aikaterini and Lazaridou, Elizabeth and Tzatzagou, Glykeria and Lambropoulos, Alexandros and Chatzikyriakidou, Anthoula},
  title = {Association of DPP4 Gene Variants with Classic and DPP4 Inhibitor-Associated Bullous Pemphigoid},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {23},
  pages = {11698},
  doi = {10.3390/ijms262311698}
}
Kostenlos starten →